DUPONT CAPITAL MANAGEMENT CORP - STEMLINE THERAPEUTICS INC ownership

STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 62 filers reported holding STEMLINE THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
DUPONT CAPITAL MANAGEMENT CORP ownership history of STEMLINE THERAPEUTICS INC
ValueSharesWeighting
Q2 2015$334,000
-5.4%
28,410
+16.6%
0.01%0.0%
Q1 2015$353,000
-9.9%
24,370
+6.0%
0.01%0.0%
Q4 2014$392,000
+8.9%
22,980
-20.6%
0.01%
+16.7%
Q3 2014$360,000
-36.7%
28,930
-25.5%
0.01%
-33.3%
Q2 2014$569,00038,8100.01%
Other shareholders
STEMLINE THERAPEUTICS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Lyon Street Capital, LLC 762,941$7,248,0007.29%
NEXTHERA CAPITAL LP 711,558$6,760,0002.79%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 585,930$4,366,0002.71%
Consonance Capital Management LP 1,155,793$10,980,0000.81%
Pier Capital, LLC 423,667$4,025,0000.80%
KNOTT DAVID M 155,795$1,480,0000.70%
Eventide Asset Management 1,086,400$10,321,0000.46%
Empire Life Investments Inc. 373,863$3,552,0000.32%
Telemetry Investments, L.L.C. 41,588$395,0000.25%
Polar Capital LLP 2,302,666$21,875,0000.23%
View complete list of STEMLINE THERAPEUTICS INC shareholders